Goelzer Investment Management Inc. bought a new position in Clorox Co (NYSE:CLX) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 1,225 shares of the company’s stock, valued at approximately $212,000.

Other institutional investors have also recently modified their holdings of the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its holdings in Clorox by 21.1% in the 4th quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 305,672 shares of the company’s stock worth $46,933,000 after buying an additional 53,246 shares during the period. Bank of New York Mellon Corp lifted its stake in Clorox by 2.3% in the 4th quarter. Bank of New York Mellon Corp now owns 1,538,660 shares of the company’s stock worth $236,246,000 after purchasing an additional 34,403 shares in the last quarter. Brookstone Capital Management lifted its stake in Clorox by 2.0% in the 4th quarter. Brookstone Capital Management now owns 4,707 shares of the company’s stock worth $723,000 after purchasing an additional 92 shares in the last quarter. Cpwm LLC purchased a new stake in Clorox in the 4th quarter worth $202,000. Finally, Wedbush Securities Inc. lifted its stake in Clorox by 1.3% in the 4th quarter. Wedbush Securities Inc. now owns 5,181 shares of the company’s stock worth $795,000 after purchasing an additional 65 shares in the last quarter. 80.05% of the stock is owned by institutional investors.

In other Clorox news, SVP William S. Bailey sold 7,969 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $207.53, for a total transaction of $1,653,806.57. Following the completion of the transaction, the senior vice president now owns 15,172 shares in the company, valued at approximately $3,148,645.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Benno O. Dorer sold 252,794 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $169.01, for a total transaction of $42,724,713.94. Following the transaction, the chief executive officer now owns 306,908 shares of the company’s stock, valued at approximately $51,870,521.08. The disclosure for this sale can be found here. Insiders have sold 300,843 shares of company stock worth $52,556,301 over the last ninety days. 1.14% of the stock is owned by insiders.

Several analysts have commented on the stock. UBS Group boosted their price target on shares of Clorox from $155.00 to $168.00 and gave the stock a “sell” rating in a research note on Monday, May 4th. Argus upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $195.00 target price on the stock in a research report on Monday, March 9th. Credit Suisse Group upped their target price on shares of Clorox from $172.00 to $180.00 and gave the company a “neutral” rating in a research report on Monday, May 4th. Cfra upped their target price on shares of Clorox from $170.00 to $190.00 and gave the company a “hold” rating in a research report on Friday, May 1st. Finally, JPMorgan Chase & Co. upgraded shares of Clorox from an “underweight” rating to an “overweight” rating and upped their target price for the company from $153.00 to $185.00 in a research report on Monday, March 16th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company’s stock. Clorox has a consensus rating of “Hold” and an average price target of $173.23.

Shares of Clorox stock opened at $209.83 on Friday. The stock has a market cap of $26.05 billion, a PE ratio of 30.77, a price-to-earnings-growth ratio of 5.13 and a beta of 0.24. The company has a debt-to-equity ratio of 3.69, a current ratio of 0.98 and a quick ratio of 0.72. The firm has a fifty day moving average price of $188.41 and a 200 day moving average price of $165.17. Clorox Co has a 1 year low of $144.12 and a 1 year high of $214.26.

Clorox (NYSE:CLX) last announced its earnings results on Friday, May 1st. The company reported $1.89 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.72 by $0.17. The business had revenue of $1.78 billion for the quarter, compared to analyst estimates of $1.69 billion. Clorox had a net margin of 13.67% and a return on equity of 147.52%. The company’s revenue for the quarter was up 15.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.44 earnings per share. As a group, equities analysts expect that Clorox Co will post 6.89 EPS for the current year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: Margin

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.